Healthy Under Stress mindfulness and lifestyle program to reduce stress
Official title: Effect of a Mindfulnes Program "Healthy Under Stress" on Stress and Stress-associated Parameters: A Prospective Intervention Study
Run by University Hospital Tuebingen · NCT06431087 · Data updated 2026-11-12
This eight-week mindfulness and healthy lifestyle program tries to reduce perceived stress in employees, patients, and family members connected with the Robert-Bosch-Krankenhaus and Bosch Health Campus by teaching mindfulness, nutrition, exercise, relaxation, and communication skills.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 120 (estimated) |
| Sponsor | University Hospital Tuebingen Academic / other |
| Locations | 1 site (Stuttgart, Baden Würtenberg) |
| Status | Recruiting |
| Started | July 8, 2024 |
| Main results expected | August 30, 2027 |
| Study ends | February 28, 2028 |
| Registry record updated | March 12, 2026 |
| Trial ID | NCT06431087 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are employees, patients, or family members of the Robert-Bosch-Krankenhaus and Bosch Health Campus who report subjective stress, can consent, and have sufficient German language skills to participate.
✕Probably not a fit
People with physical or mental conditions that prevent participation, those who cannot speak German, or those already in other behavioral or complementary-intervention studies are unlikely to benefit from this program.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Participants complete a baseline visit and then attend eight weekly two-hour group sessions covering mindfulness, nutrition, exercise, relaxation techniques, stressor management, communication, and social support. The main outcome is change in perceived stress measured with the Perceived Stress Scale (PSS) at the end of the program and again three months after baseline. The intervention is delivered in-person at the Robert-Bosch-Krankenhaus and is open to the hospital community who can give informed consent and speak German. Those with medical or mental conditions that would prevent safe participation or who are enrolled in similar behavioral studies are excluded.
Why it matters
Potential benefit: If successful, the program could lower perceived stress and improve coping and day-to-day wellbeing for participants.
How similar studies have gone: Previous mindfulness- and lifestyle-based programs have shown reductions in perceived stress in multiple trials, so this approach builds on existing evidence rather than being entirely novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Employees, patients and family members of the Robert-Bosch-Krankenhaus (RBK) and Bosch Health Campus of all specialties. * Informed consent. Exclusion Criteria: * Physical or mental condition which, in the opinion of the investigator does not allow the patient to participate in the study. * Participation in other clinical studies with behavioral, psychological or complementary medical interventions. * Insufficient knowledge of the German language.
Where it's running
-
Robert-Bosch-Krankenhaus
Stuttgart, Baden Würtenberg, Germany Recruiting
Study contacts
- Study coordinator: Marcela Winkler, Dr
- Email: marcela.winkler@rbk.de
- Phone: +49711 8181
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Digital cognitive check after a stroke in people with severe disability
This study tests how well a digital cognitive assessment app (TuCAN-App) can track recovery in adults who had a major stroke and were severely disabled.
-
Multi-peptide Vaccination and PSMAxCD3 Antibody Therapy for Prostate Cancer with Biochemical Recurrence
This phase 2 trial tests whether a PSMA-targeted bispecific antibody (CC-1), a prostate cancer peptide vaccine (VAC-XS15-PC01), or both can be given safely and help control biochemical recurrence after local therapy in men with prostate cancer.
-
Detecting cardiac amyloidosis in people with severe aortic valve narrowing
This study tests non-invasively whether imaging tests can find heart amyloidosis in patients with severe aortic stenosis who are being evaluated for valve replacement.
-
Low-thermal Argon Plasma Devitalization for CIN2 Treatment
This study tests whether a low-thermal argon plasma treatment can heal CIN2 on the cervix better than a sham procedure or active surveillance in women aged 18–40.
-
Real-time AI detection of surgical smoke during endoscopic laparoscopic procedures
This pilot will test whether an AI system can detect surgical smoke in real time from endoscopic video during laparoscopic procedures that use high-frequency surgical devices.
-
Comparing open and robot-assisted removal of groin lymph nodes for penile cancer
This trial will test whether robot-assisted groin lymph node removal causes fewer complications and faster recovery than standard open surgery for men with penile squamous cell carcinoma who need lymphadenectomy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.